AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 147 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $56,029,892 | -23.4% | 2,263,834 | -12.3% | 0.00% | -25.0% |
| Q2 2023 | $73,107,202 | +3.9% | 2,581,469 | -15.7% | 0.00% | 0.0% |
| Q1 2023 | $70,380,126 | -60.6% | 3,064,002 | -51.8% | 0.00% | -20.0% |
| Q4 2022 | $178,536,458 | +139.6% | 6,358,136 | +141.3% | 0.01% | 0.0% |
| Q3 2022 | $74,511,000 | -1.2% | 2,634,772 | -22.5% | 0.01% | 0.0% |
| Q2 2022 | $75,405,000 | -18.7% | 3,401,219 | +6.7% | 0.01% | 0.0% |
| Q1 2022 | $92,759,000 | -5.7% | 3,186,513 | +6.5% | 0.01% | 0.0% |
| Q4 2021 | $98,376,000 | -10.9% | 2,992,882 | +25.1% | 0.01% | -16.7% |
| Q3 2021 | $110,432,000 | +1.7% | 2,392,890 | +21.5% | 0.01% | 0.0% |
| Q2 2021 | $108,570,000 | +21.3% | 1,970,059 | +13.7% | 0.01% | +20.0% |
| Q1 2021 | $89,471,000 | -21.3% | 1,732,590 | -33.9% | 0.01% | -28.6% |
| Q4 2020 | $113,623,000 | +57.1% | 2,622,281 | +26.9% | 0.01% | +40.0% |
| Q3 2020 | $72,346,000 | -28.6% | 2,067,022 | +9.1% | 0.01% | -28.6% |
| Q2 2020 | $101,325,000 | +49.6% | 1,894,628 | -0.8% | 0.01% | +16.7% |
| Q1 2020 | $67,742,000 | -24.7% | 1,909,309 | +1.3% | 0.01% | 0.0% |
| Q4 2019 | $89,999,000 | +50.0% | 1,884,786 | +1.8% | 0.01% | +50.0% |
| Q3 2019 | $59,983,000 | -31.2% | 1,851,337 | +6.0% | 0.00% | -33.3% |
| Q2 2019 | $87,146,000 | -18.7% | 1,747,115 | +9.9% | 0.01% | -25.0% |
| Q1 2019 | $107,201,000 | +41.3% | 1,589,571 | -3.4% | 0.01% | +14.3% |
| Q4 2018 | $75,894,000 | -37.0% | 1,645,928 | +5.4% | 0.01% | -22.2% |
| Q3 2018 | $120,460,000 | +6.1% | 1,561,981 | +15.8% | 0.01% | 0.0% |
| Q2 2018 | $113,587,000 | -6.8% | 1,348,516 | -9.5% | 0.01% | -10.0% |
| Q1 2018 | $121,814,000 | +58.7% | 1,489,508 | +10.9% | 0.01% | +66.7% |
| Q4 2017 | $76,750,000 | -8.4% | 1,342,639 | +6.9% | 0.01% | -14.3% |
| Q3 2017 | $83,816,000 | +25.0% | 1,255,721 | -3.6% | 0.01% | +16.7% |
| Q2 2017 | $67,036,000 | -4.8% | 1,302,966 | +8.1% | 0.01% | 0.0% |
| Q1 2017 | $70,417,000 | +36.0% | 1,205,746 | -2.8% | 0.01% | +20.0% |
| Q4 2016 | $51,772,000 | -10.1% | 1,240,585 | +13.8% | 0.01% | -16.7% |
| Q3 2016 | $57,594,000 | +52.9% | 1,090,341 | +21.3% | 0.01% | +50.0% |
| Q2 2016 | $37,672,000 | -15.9% | 899,186 | -18.5% | 0.00% | -20.0% |
| Q1 2016 | $44,803,000 | -23.6% | 1,103,662 | +22.2% | 0.01% | -16.7% |
| Q4 2015 | $58,631,000 | +42.6% | 903,194 | +55.1% | 0.01% | +20.0% |
| Q3 2015 | $41,105,000 | -21.9% | 582,347 | +22.9% | 0.01% | -16.7% |
| Q2 2015 | $52,663,000 | +25.0% | 473,881 | +6.1% | 0.01% | +50.0% |
| Q1 2015 | $42,131,000 | +0.7% | 446,763 | +19.7% | 0.00% | 0.0% |
| Q4 2014 | $41,830,000 | +25.3% | 373,383 | -31.4% | 0.00% | 0.0% |
| Q3 2014 | $33,385,000 | +318.8% | 544,184 | +212.9% | 0.00% | +300.0% |
| Q2 2014 | $7,971,000 | +129.3% | 173,898 | +95.9% | 0.00% | – |
| Q1 2014 | $3,476,000 | +77.0% | 88,781 | +8.2% | 0.00% | – |
| Q4 2013 | $1,964,000 | +23.9% | 82,021 | +44.7% | 0.00% | – |
| Q3 2013 | $1,585,000 | – | 56,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |